A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Archives of Dermatology

• Publication date

  1984-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHDERM.1984.01650390051010PMID 6367665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long‐Term Antihypertensive Therapy with Prazosin Plus a Diuretic

  1979cited by this paper
• Drug therapy. Prazosin.

  1979cited by this paper
• Responsiveness to prazosin in renal failure.

  1979cited by this paper
• Prazosin, pharmacokinetics and concentration effect

  1979cited by this paper
• Prazosin relieves Raynaud's vasospasm.

  1979cited by this paper
• The metabolic fate of prazosin.

  1977cited by this paper
• Vasodilators in Peripheral Vascular Disease

  1950cited by this paper

• S2k-Leitlinie „Diagnostik und Therapie der systemischen Sklerose“

  2025cites this paper
• Systematic literature review to inform the Portuguese recommendations for the management of Raynaud's phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases.

  2024cites this paper
• Practical management of Raynaud's phenomenon – a primer for practicing physicians

  2022cites this paper
• Systemic scleroderma.

  2020cites this paper
• Comparative efficacy and safety of treatments for secondary Raynaud's phenomenon: a systematic review and network meta-analysis of randomised trials.

  2019cites this paper
• Systemic sclerosis: Current concepts of skin and systemic manifestations.

  2018cites this paper
• Efficacy of Raynaud’s phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review

  2015cites this paper
• Treatment options in Raynaud's phenomenon

  2014cites this paper
• Recomendações sobre diagnóstico e tratamento da esclerose sistêmica

  2013cites this paper
• Chapter 40 – Cold-induced injury: Frostbite

  2012cites this paper
• The Current Treatment of Scleroderma

  2012cites this paper
• Effectiveness of interventions for secondary Raynaud's phenomenon: a systematic review.

  2011cites this paper
• Zum Einfluss von Tiefenoszillation und Biofeedback auf subjektive Krankheits-wahrnehmung und Gewebsbefunde bei systemischer Sklerodermie

  2011cites this paper
• The ‘Connective Tissue Diseases’

  2010cites this paper
• Recent Advances in the Treatment of Systemic Sclerosis

  2009cites this paper
• The Challenge of Scleroderma Ulcers

  2009cites this paper
• MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.

  2009cites this paper
• Pharmacological treatment of Raynaud's phenomenon with special reference to calcium-entry blockers.

  2009cites this paper
• Síndrome de Raynaud: etiología y manejo

  2008cites this paper
• [Not Available].

  2008cites this paper
• Raynaud's Phenomenon: Etiology and Management

  2008cites this paper
• Assessment of unmet needs and the lack of generalizability in the design of randomized controlled trials for scleroderma treatment.

  2008cites this paper
• Therapeutic Options for Digital Ulcers in Patients with Systemic Sclerosis

  2007cites this paper
• Therapeutische Optionen für digitale Ulzera bei Patienten mit systemischer Sklerodermie

  2007cites this paper
• [Therapeutic management of acral manifestations of systemic sclerosis].

  2007cites this paper
• Therapeutisches Management akraler Manifestationen der systemischen Sklerose

  2007cites this paper
• Effects of Calcium Antagonists on a-Adrenoceptor Mediated Vasoconstrictions of the Canine Intermediate Auricular Artery

  2006cites this paper
• Sklerodermie und sklerodermiforme Dermatosen

  2002cites this paper
• Design and quality considerations for randomized controlled trials in systemic sclerosis.

  2002cites this paper
• Prazosin for Raynaud's phenomenon in progressive systemic sclerosis.

  1998cites this paper
• Comprehensive management of Raynaud's syndrome.

  1997cites this paper
• Cold-Induced Skin Disorders

  1996cites this paper
• Cardiac involvement in scleroderma.

  1996cites this paper
• Recent developments in the therapy of localized and systemic sclerosis.

  1994cites this paper
• The treatment of Raynaud's phenomenon.

  1994cites this paper
• Hydrocolloidal dressings — A new generation of substances for the treatment of wounds and burns (review)

  1994cites this paper
• Southwestern Internal Medicine Conference: The Many Faces of Scleroderma

  1992cites this paper
• The many faces of scleroderma.

  1992cites this paper
• [Current status and trends in treatment of scleroderma].

  1992cites this paper
• Treatment of systemic sclerosis.

  1991cites this paper
• Southwestern Internal Medicine Conference: Clinical Features, Pathogenic Mechanisms, and New Developments in the Treatment of Systemic Sclerosis

  1990cites this paper
• Treatment of systemic sclerosis in 1988.

  1989cites this paper
• Treatment of systemic sclerosis.

  1989cites this paper
• Treatment of systemic sclerosis.

  1989cites this paper
• Temperature-dependent skin disorders.

  1988cites this paper
• [Medical treatment of Raynaud's syndrome].

  1988cites this paper
• Dose‐Response Study of Prazosin in Raynaud's Phenomenon: Clinical Effectiveness Versus Side Effects

  1988cites this paper
• Le traitement médical du syndrome de Raynaud

  1988cites this paper
• [Treatment of Raynaud's phenomenon].

  1987cites this paper
• Behavioral Treatment of Raynaud’s Syndrome

  1987cites this paper
• Effects of calcium antagonists on alpha-adrenoceptor mediated vasoconstrictions of the canine intermediate auricular artery.

  1987cites this paper
• Drug treatment in Raynaud's phenomenon.

  1987cites this paper
• The role of the sympathetic nervous system in the pathophysiology and therapy of Raynaud's phenomenon.

  1987cites this paper
• Successful symptomatic treatment of melorheostosis with nifedipine.

  1986cites this paper
• Nifedipine and alpha 1-adrenergic blockade in Raynaud's phenomenon.

  1985cites this paper
• Dermatologic therapy: December 1983 through November 1984.

  1985cites this paper
• CHAPTER 5 – Scleroderma

  1985cites this paper
• Cold-induced Injury Cold-induced Injury Introduction Mechanisms of Heat Loss Conduction Convection Radiation Evaporation Respiration Factors Influencing Heat Loss Weather and Duration of Exposure Type of Combat Action Clothing Other Factors Pathogenesis of Cold Injury Direct Cold Injury Asteatotic E

  year unknowncites this paper